Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer
Clinical trial NCT04358341 · UNKNOWN
Trial details
- NCT number
- NCT04358341
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2022-06-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.